Business Strategy
FXT’s mission is to advance to clinical proof of concept a portfolio of proprietary, first in class therapeutics in the area of inflammation by leveraging its competencies in early stage development.
FXT will partner with inflammation disease franchise leaders to accelerate late stage clinical development and launch its products into patient markets.